Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions

被引:28
|
作者
Eriksen, Peter Lykke [1 ]
Sorensen, Michael [1 ]
Gronbaek, Henning [1 ]
Hamilton-Dutoit, Stephen [2 ]
Vilstrup, Hendrik [1 ]
Thomsen, Karen Louise [1 ]
机构
[1] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark
[2] Aarhus Univ Hosp, Inst Pathol, Palle Juul Jensens Blvd 99, Aarhus, Denmark
关键词
Non-alcoholic steatohepatitis; Liver function tests; Hepatic elimination; Urea cycle; Aminopyrine; Indocyanine green; GALACTOSE ELIMINATION CAPACITY; BODY-SURFACE AREA; HEPATIC ELIMINATION; INDOCYANINE GREEN; UREA SYNTHESIS; NORMAL-WEIGHT; BREATH TESTS; FIBROSIS; PROGRESSION; STEATOSIS;
D O I
10.1016/j.clinre.2019.01.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Non-alcoholic fatty liver disease (NAFLD) is a major health concern affecting 25% of the world's population. It is generally held that a fatty liver does not influence liver function, but quantitative measurements of metabolic liver functions have not been systematically performed. We aimed to study selected hepatocetlular metabolic functions in patients with different stages of NAFLD. Methods: Twenty-five non-diabetic, biopsy-proven NAFLD patients [12 with simple steatosis; 13 with non-alcoholic steatohepatitis (NASH)] and ten healthy controls were included in a cross-sectional study. Hepatocyte cytosolic function was assessed by the galactose elimination capacity (GEC), mitochondrial-cytosolic metabolic capacity by the functional hepatic nitrogen clearance (FHNC), microsomal function by the aminopyrine breath test, and excretory liver function by indocyanine green (ICG) elimination. Results: GEC was 20% higher in NAFLD than in controls [3.15 mmol/min (2.9-3.41) vs. 2.62 (2.32-2.93); P=0.02]. FHNC was 30% lower in NAFLD [23.3 L/h (18.7-28.9) vs. 33.1 (28.9-37.9); P=0.04], more so in simple steatosis [19.1 L/h (13.9-26.2); P=0.003] and non-significantly in NASH [27.9 L/h (20.6-37.8); P=0.19]. Aminopyrine metabolism was 25% lower in simple steatosis [8.9% (7.0-10.7)] and 50% lower in NASH [6.0% (4.5-7.5)] than in controls [11.9% (9.3-12.8)] (P<0.001). KG elimination was intact. Conclusions: The hepatocellular metabolic functions were altered in a manner that was dissociated both by different effects on different liver functions and by different effects of different stages of NAFLD. Thus, NAFLD has widespread consequences for metabolic liver function, even in simple steatosis. (C) 2019 Published by Elsevier Masson SAS.
引用
收藏
页码:551 / 560
页数:10
相关论文
共 50 条
  • [11] Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
    McGlinchey, Aidan J.
    Govaere, Olivier
    Geng, Dawei
    Ratziu, Vlad
    Allison, Michael
    Bousier, Jerome
    Petta, Salvatore
    de Oliviera, Claudia
    Bugianesi, Elisabetta
    Schattenberg, Jorn M.
    Daly, Ann K.
    Hyotylainen, Tuulia
    Anstee, Quentin M.
    Oresic, Matej
    JHEP REPORTS, 2022, 4 (05)
  • [12] Natural history of non-alcoholic fatty liver disease
    Pais, R.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2022, 26 (03): : 88 - 92
  • [13] Diagnosis of non-alcoholic fatty liver disease (NAFLD)
    Yki-Jarvinen, Hannele
    DIABETOLOGIA, 2016, 59 (06) : 1104 - 1111
  • [14] Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
    Valenzuela-Vallejo, Laura
    Sanoudou, Despina
    Mantzoros, Christos S.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [15] Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
    Devi, Jalpa
    Raees, Aimun
    Butt, Amna Subhan
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (01) : 158 - 167
  • [16] Non-invasive diagnosis: non-alcoholic fatty liver disease and alcoholic liver disease
    Altamirano, Jose
    Qi, Qiaochu
    Choudhry, Sabina
    Abdallah, Mohamed
    Singal, Ashwani K.
    Humar, Abhinav
    Bataller, Ramon
    Borhani, Amir Ali
    Duarte-Rojo, Andres
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [17] Non-alcoholic fatty liver disease proteomics
    Rodriguez-Suarez, Eva
    Duce, Antonio M.
    Caballeria, Juan
    Martinez Arrieta, Felix
    Fernandez, Estefania
    Gomara, Carolina
    Alkorta, Nere
    Ariz, Usue
    Luz Martinez-Chantar, M.
    Lu, Shelly C.
    Elortza, Felix
    Mato, Jose M.
    PROTEOMICS CLINICAL APPLICATIONS, 2010, 4 (04) : 362 - 371
  • [18] Platelets in Non-alcoholic Fatty Liver Disease
    Dalbeni, Andrea
    Castelli, Marco
    Zoncape, Mirko
    Minuz, Pietro
    Sacerdoti, David
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [19] Carotenoids and non-alcoholic fatty liver disease
    Yilmaz, Bahiddin
    Sahin, Kazim
    Bilen, Hande
    Bahcecioglu, Ibrahim H.
    Bilir, Birdal
    Ashraf, Sara
    Halazun, Karim J.
    Kucuk, Omer
    HEPATOBILIARY SURGERY AND NUTRITION, 2015, 4 (03) : 161 - 171
  • [20] Pathology of non-alcoholic fatty liver disease
    Cataldo, Ivana
    Sarcognato, Samantha
    Sacchi, Diana
    Cacciatore, Matilde
    Baciorri, Francesca
    Mangia, Alessandra
    Cazzagon, Nora
    Guido, Maria
    PATHOLOGICA, 2021, 113 (03) : 194 - 202